[조사자료] 세계의 차세대 시퀀싱 (NGS) 시장 (~2027년) : 제품 및 서비스별 (소모품, 플랫폼, 서비스), 기술별 (SBS, 나노포어), 용별도 (진단, 신약 개발, 농업), 최종 용도별 (제약, 생명 공학, 교육)

■ 영문 제목 : Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
	■ 상품코드 : BT2697-23 ■ 조사/발행회사 : MarketsandMarkets ■ 발행일 : 2023년 1월 ■ 페이지수 : 456 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오테크놀로지

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD4,950 ⇒환산￦6,682,500	견적의뢰/주문/질문
Five User (5인 열람용)	USD6,650 ⇒환산￦8,977,500	견적의뢰/주문/질문
Corporate License (동일 법인내 공유가능)	USD8,150 ⇒환산￦11,002,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

MarketsandMarkets사는 세계의 차세대 시퀀싱 (NGS) 시장 규모가 2022년 130억 달러에서 2027년 270억 달러에 이르며, 예측 기간 동안 연평균 15.7%로 성장할 것으로 추정하고 있습니다. 본 조사 보고서는 세계의 차세대 시퀀싱 (NGS) 시장을 조사 및 분석하여, 소개, 조사 방법, 개요, 프리미엄 인사이트, 시장 개요, 제품 및 서비스별 (NGS 소모품, 시퀀싱 서비스, 프리시퀀스 제품 및 서비스, NGS 플랫폼, 바이오 인포매틱스) 분석, 기술별 (SBS, 나노포어 시퀀싱, 1분자 실시간 시퀀싱, 기타) 분석, 용도별 (진단, 신약 개발, 농업 및 동물학 연구) 분석, 최종 용도별 (학술 기관&연구 기관, 제약&바이오테크놀로지 기업, 병원&클리닉, 레퍼런스 실험실) 분석, 지역별 (북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카) 분석, 경쟁 현황, 기업 정보 등의 항목을 게재하고 있습니다. 또한 본 조사 자료는 Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US) 등의 기업 정보를 포함하고 있습니다.
· 소개
· 조사 방법
· 개요
· 프리미엄 인사이트
· 시장 개요
· 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 제품 및 서비스별
- NGS 소모품의 시장 규모
- 시퀀싱 서비스의 시장 규모
- 프리시퀀스 제품 및 서비스의 시장 규모
- NGS 플랫폼의 시장 규모
- 바이오인포매틱스의 시장 규모
· 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 기술별
- SBS 기술의 시장 규모
- 나노포어 시퀀싱 기술의 시장 규모
- 1분자 실시간 시퀀싱 기술의 시장 규모
- 기타 기술의 시장 규모
· 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 용도별
- 진단에 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
- 신약 개발에 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
- 농업 및 동물학 연구에 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
· 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 최종 용도별
- 학술 기관 및 연구 기관에서 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
- 제약&바이오테크놀로지 기업에서 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
- 병원 및 클리닉에서 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
- 레퍼런스 실험실에서 사용되는 차세대 시퀀싱 (NGS)의 시장 규모
· 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 지역별
- 북미의 차세대 시퀀싱 (NGS) 시장 규모
- 유럽의 차세대 시퀀싱 (NGS) 시장 규모
- 아시아 태평양의 차세대 시퀀싱 (NGS) 시장 규모
- 남미의 차세대 시퀀싱 (NGS) 시장 규모
- 중동 및 아프리카의 차세대 시퀀싱 (NGS) 시장 규모
· 경쟁 현황
· 기업 정보

■ 보고서 개요

“The global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027.” Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.
Consumables segment accounted for the largest share of next-generation sequencing market On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.

“Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market”
Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.

The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).

“North America: Accounted for the largest share in the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side – 20%
• By Designation: Managers- 45%, CXOs and Director level – 30%, and Executives – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:
• Illumina (US)
• Thermo Fisher Scientific (US)
• PerkinElmer (US)
• BGI Group (China)
• Agilent Technologies (US)
• Eurofins Scientific (Luxembourg)
• Pacific Biosciences (US)
• Oxford Nanopore Technologies (UK)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche AG (Switzerland)
• Brooks Automation (US)
• Psomagen, Inc. (US)
• 10x Genomics (US)
• Tecan Group (Switzerland)
• Zymo Research (US)
• Takara Bio (Japan)
• Promega Corporation (US)
• CD Genomics (US)
• New England Biolabs (US)
• Novogene Corporation (China)
• Hamilton Company (US)
• MedGenome (US)
• Becton, Dickinson and Company (US)
• Genotypic Technology (India)
• LGC Limited (US)

Research Coverage:
This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

■ 보고서 목차

1 INTRODUCTION 57
1.1 STUDY OBJECTIVES 57
1.2 MARKET DEFINITION 57
1.2.1 INCLUSIONS AND EXCLUSIONS 57
1.3 MARKET SCOPE 58
FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION 58
1.3.1 YEARS CONSIDERED 59
1.4 CURRENCY CONSIDERED 59
1.5 LIMITATIONS 59
1.6 STAKEHOLDERS 60
1.7 SUMMARY OF CHANGES 60
2 RESEARCH METHODOLOGY 61
2.1 RESEARCH APPROACH 61
FIGURE 2 RESEARCH DESIGN 61
2.1.1 PRIMARY RESEARCH 62
FIGURE 3 NEXT-GENERATION SEQUENCING MARKET: PRIMARY RESPONDENTS 62
2.2 MARKET ESTIMATION METHODOLOGY 63
FIGURE 4 NEXT-GENERATION SEQUENCING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021 63
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021 64
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 65
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 65
2.3 MARKET GROWTH RATE PROJECTIONS 66
FIGURE 7 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2022–2027 67
FIGURE 8 NEXT-GENERATION SEQUENCING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 68
2.4 DATA TRIANGULATION 69
FIGURE 9 DATA TRIANGULATION METHODOLOGY 69
2.5 RESEARCH ASSUMPTIONS 69
2.6 RISK ANALYSIS 70
2.7 RECESSION IMPACT 70
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 70
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 71
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 71

3 EXECUTIVE SUMMARY 72
FIGURE 10 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 72
FIGURE 11 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 73
FIGURE 12 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 74
FIGURE 13 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 75
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEXT-GENERATION SEQUENCING MARKET 76
4 PREMIUM INSIGHTS 77
4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 77
FIGURE 15 ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH 77
4.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 78
FIGURE 16 NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 78
4.3 NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 2027 79
FIGURE 17 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027 79
4.4 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 79
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 79
5 MARKET OVERVIEW 80
5.1 INTRODUCTION 80
5.2 MARKET DYNAMICS 80
FIGURE 19 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80
TABLE 4 NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81
5.2.1 DRIVERS 81
5.2.1.1 Advancements in NGS platforms 81
5.2.1.1.1 PromethION 2 Solo 82
5.2.1.1.2 Ion Torrent Genexus Dx 82
5.2.1.1.3 iSeq 100 system 82
5.2.1.1.4 Ion GeneStudio S5 82
5.2.1.2 Declining cost of genome sequencing 82
FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2021 83
5.2.1.3 Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests 83
5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research 84
FIGURE 21 NUMBER OF NEW CANCER CASES WORLDWIDE, 2020 84
TABLE 5 CANCER INCIDENCE, 2020 VS. 2040 84
5.2.2 RESTRAINTS 85
5.2.2.1 End-user budget constraints in developing countries 85
5.2.3 OPPORTUNITIES 85
5.2.3.1 Application of NGS in precision medicine and molecular diagnostics 85
5.2.3.2 Government and private support for large-scale sequencing 86
TABLE 6 GLOBAL SEQUENCING INITIATIVES 86
5.2.3.3 Advancements in NGS data analysis using big data 87
FIGURE 22 DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–2019 87
5.2.3.4 Development of portable sequencing technologies 88
5.2.3.5 Partnerships and collaborations for technological advancements in NGS 88
TABLE 7 PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018–DECEMBER 2022 88
5.2.4 CHALLENGES 89
5.2.4.1 Interpretation of complex data from NGS platforms 89
5.2.4.2 Ethical issues 89
5.2.4.3 Introduction of alternative technologies 89
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS 90
5.4 PRICING ANALYSIS 90
TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021) 90
5.5 TECHNOLOGY ANALYSIS 91
TABLE 9 SANGER SEQUENCING VS. NGS 91
5.6 VALUE CHAIN ANALYSIS 92
FIGURE 24 VALUE CHAIN ANALYSIS OF NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE 92
FIGURE 25 VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES 93
5.7 ECOSYSTEM ANALYSIS 94
FIGURE 26 ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET 94
TABLE 10 SUPPLY CHAIN ECOSYSTEM 94
5.8 KEY CONFERENCES AND EVENTS IN 2023–2024 96
TABLE 11 NEXT-GENERATION SEQUENCING MARKET: LIST OF CONFERENCES AND EVENTS 96
5.9 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 12 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.9.1 THREAT OF NEW ENTRANTS 97
5.9.2 THREAT OF SUBSTITUTES 97
5.9.3 BARGAINING POWER OF SUPPLIERS 97
5.9.4 BARGAINING POWER OF BUYERS 98
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 98
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 98
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES 98
FIGURE 28 BUYING CRITERIA FOR NGS PRODUCTS 98
5.11 PATENT ANALYSIS 99
FIGURE 29 PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012–DECEMBER 2022 99
5.12 REGULATORY ANALYSIS 100
5.12.1 NORTH AMERICA 100
5.12.1.1 US 100
TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION 101
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 101
5.12.1.2 Canada 101
5.12.2 EUROPE 101
5.12.3 ASIA PACIFIC 102
5.12.3.1 China 102
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES 102
5.12.3.2 Japan 103
5.12.3.3 India 103
5.12.4 LATIN AMERICA 103
5.12.5 MIDDLE EAST 104
6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE 105
6.1 INTRODUCTION 106
TABLE 16 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 106
6.2 NGS CONSUMABLES 106
6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES 106
TABLE 17 NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 107
TABLE 18 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 19 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 20 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 21 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 22 MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.3 SEQUENCING SERVICES 109
TABLE 23 SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 24 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 25 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 26 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 27 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 28 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 29 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 111
6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS 112
6.3.1.1 Development of technologically advanced NGS products and services to propel growth 112
TABLE 30 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION) 112
TABLE 31 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 32 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 33 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 34 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 35 MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION) 114
6.3.2 RNA SEQUENCING 115
6.3.2.1 Launch of RNA sequencing services to drive growth 115
TABLE 36 RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 115
TABLE 37 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 38 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 39 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 40 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 41 MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 117
6.3.3 DE NOVO SEQUENCING 117
6.3.3.1 Rising awareness about advantages of De Novo sequencing to support growth 117
TABLE 42 DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 118
TABLE 43 NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 44 EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 45 ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 46 LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 47 MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 120

6.3.4 CHIP SEQUENCING 120
6.3.4.1 Increasing demand for ChIP sequencing services to propel growth 120
TABLE 48 CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 121
TABLE 49 NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 50 EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 51 ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 52 LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 53 MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 123
6.3.5 WHOLE-GENOME SEQUENCING 123
6.3.5.1 Reducing whole-genome sequencing costs to propel growth 123
TABLE 54 WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 124
TABLE 55 NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 56 EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 57 ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 58 LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 59 MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 125
6.3.6 METHYL SEQUENCING 126
6.3.6.1 Rising importance of DNA methylation in study of cancer to drive growth 126
TABLE 60 METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 126
TABLE 61 NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 62 EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 63 ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 64 LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 65 MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 128
6.3.7 OTHER SEQUENCING SERVICES 128
TABLE 66 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 128
TABLE 67 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 68 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 69 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 70 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 71 MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 130
6.4 PRE-SEQUENCING PRODUCTS & SERVICES 130
TABLE 72 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 73 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 131
TABLE 74 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 75 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 76 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 77 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 78 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 133
6.4.1 LIBRARY PREPARATION AND TARGET ENRICHMENT 133
6.4.1.1 Development of advanced library preparation solutions to boost growth 133
TABLE 79 LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 80 NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
TABLE 81 EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 82 ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 83 LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 84 MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 137
6.4.2 QUALITY CONTROL 137
6.4.2.1 Importance of quality control in NGS workflow to drive growth 137
TABLE 85 QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION) 138
TABLE 86 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 87 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 88 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 89 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 90 MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION) 139
6.5 NGS PLATFORMS 140
TABLE 91 NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 92 NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 141
TABLE 93 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 94 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 95 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 96 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 97 MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 142
6.5.1 ILLUMINA 143
TABLE 98 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 99 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 144
6.5.1.1 NovaSeq systems 144
TABLE 100 NOVASEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 145
6.5.1.2 NextSeq systems 145
TABLE 101 NEXTSEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 146
6.5.1.3 MiSeq systems 146
TABLE 102 MISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 146
6.5.1.4 iSeq 100 systems 147
TABLE 103 ISEQ 100 SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 147
6.5.1.5 MiniSeq systems 147
TABLE 104 MINISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 147
6.5.2 THERMO FISHER SCIENTIFIC 148
TABLE 105 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 106 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 148
6.5.3 OXFORD NANOPORE TECHNOLOGIES 149
TABLE 107 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 149
6.5.4 PACIFIC BIOSCIENCES 150
TABLE 108 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 150
6.5.5 OTHER NGS PLATFORMS 150
TABLE 109 OTHER NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 151
6.6 BIOINFORMATICS 151
TABLE 110 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 151
TABLE 111 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION) 152
TABLE 112 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 114 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 115 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 116 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION) 153
6.6.1 NGS DATA ANALYSIS SERVICES 154
6.6.1.1 Rising awareness about NGS data analysis services to boost growth 154
TABLE 117 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 154
TABLE 118 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 154
TABLE 119 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 120 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 121 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 122 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 156
6.6.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES 156
6.6.2.1 Development of advanced bioinformatics solutions to drive growth 156
TABLE 123 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 157
TABLE 124 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 125 EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 126 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 127 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 159
TABLE 128 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 159
6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS 159
6.6.3.1 Launch of cloud-based solutions to drive market 159
TABLE 129 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 160
TABLE 130 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 131 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 132 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 133 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 134 MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 162
6.7 SERVICES FOR NGS PLATFORMS 163
6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH 163
TABLE 135 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 163
TABLE 136 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 137 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
TABLE 138 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
TABLE 139 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 140 MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 165
7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY 166
7.1 INTRODUCTION 167
TABLE 141 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY 167
TABLE 142 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168
7.2 SEQUENCING BY SYNTHESIS 168
7.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD 168
TABLE 143 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION) 169
TABLE 144 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 169
TABLE 145 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 146 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 147 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 171
TABLE 148 MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION) 171
7.3 ION SEMICONDUCTOR SEQUENCING 171
7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING 171
TABLE 149 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 172
TABLE 150 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 172
TABLE 151 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 152 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 153 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 174
TABLE 154 MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 174
7.4 NANOPORE SEQUENCING 174
7.4.1 NANOPORE SEQUENCING—ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES 174
TABLE 155 NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 175
TABLE 156 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 175
TABLE 157 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
TABLE 158 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
TABLE 159 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
TABLE 160 MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 177
7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 177
7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS 177
TABLE 161 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 178
TABLE 162 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
TABLE 163 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 164 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 165 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 166 MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 180
7.6 OTHER SEQUENCING TECHNOLOGIES 180
TABLE 167 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION) 180
TABLE 168 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 181
TABLE 169 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 181
TABLE 170 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 182
TABLE 171 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 182
TABLE 172 MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION) 182

8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 183
8.1 INTRODUCTION 184
TABLE 173 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 184
8.2 DIAGNOSTICS 184
TABLE 174 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 175 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 185
TABLE 176 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 177 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 178 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 187
TABLE 179 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 187
TABLE 180 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 187
8.2.1 CANCER DIAGNOSTICS 188
8.2.1.1 High adoption of NGS in cancer diagnostics to propel growth 188
TABLE 181 NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 189
TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 189
TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 190
TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 190
TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 191
TABLE 186 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 191
8.2.2 INFECTIOUS DISEASE DIAGNOSTICS 191
8.2.2.1 Applications in infectious disease surveillance and launch of new tests to drive growth 191
TABLE 187 NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 192
TABLE 188 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 192
TABLE 189 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 190 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 191 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 194
TABLE 192 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 194
8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 194
8.2.3.1 Extensive use of NGS in NIPT to boost growth 194
TABLE 193 NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 195
TABLE 194 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 196
TABLE 195 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 196
TABLE 196 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 197
TABLE 197 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 197
TABLE 198 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 197
8.2.4 OTHER DIAGNOSTIC APPLICATIONS 198
TABLE 199 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 198
TABLE 200 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 198
TABLE 201 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 202 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 203 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 200
TABLE 204 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 200
8.3 DRUG DISCOVERY AND DEVELOPMENT 200
TABLE 205 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 206 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 201
TABLE 207 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 202
TABLE 208 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 202
TABLE 209 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 203
TABLE 210 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 203
TABLE 211 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 203
8.3.1 PHARMACOGENOMICS 204
8.3.1.1 Advent of NGS to understand genomic variants in humans to drive growth 204
TABLE 212 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION) 204
TABLE 213 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 205
TABLE 214 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 205
TABLE 215 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 206
TABLE 216 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 206
TABLE 217 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION) 206
8.3.2 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS 207
TABLE 218 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 207
TABLE 219 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 207
TABLE 220 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 208
TABLE 221 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 208
TABLE 222 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 209
TABLE 223 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 209
8.4 AGRICULTURAL AND ANIMAL RESEARCH 209
8.4.1 NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH 209
TABLE 224 NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 210
TABLE 225 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 210
TABLE 226 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 211
TABLE 227 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 211
TABLE 228 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 212
TABLE 229 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 212

8.5 OTHER APPLICATIONS 213
TABLE 230 NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 213
TABLE 231 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 213
TABLE 232 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214
TABLE 233 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214
TABLE 234 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 215
TABLE 235 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 215
9 NEXT-GENERATION SEQUENCING MARKET, BY END USER 216
9.1 INTRODUCTION 217
TABLE 236 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 217
9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS 217
9.2.1 ACADEMIC AND RESEARCH INSTITUTES TO ACCOUNT FOR LARGEST MARKET SHARE 217
TABLE 237 NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION) 218
TABLE 238 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 218
TABLE 239 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 219
TABLE 240 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 219
TABLE 241 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 220
TABLE 242 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION) 220
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 220
9.3.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH 220
TABLE 243 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 221
TABLE 244 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 221
TABLE 245 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 222
TABLE 246 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 222
TABLE 247 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 223
TABLE 248 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 223
9.4 HOSPITALS AND CLINICS 223
9.4.1 EXPANDING USE OF NGS IN HOSPITALS AND CLINICS TO BOOST GROWTH 223
TABLE 249 NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 224
TABLE 250 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 224
TABLE 251 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 225
TABLE 252 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 225
TABLE 253 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 226
TABLE 254 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 226
9.5 REFERENCE LABORATORIES 226
9.5.1 INCREASING AVAILABILITY OF TESTING SOLUTIONS AND HIGH ADOPTION OF NGS IN REFERENCE LABORATORIES TO DRIVE GROWTH 226
TABLE 255 NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 227
TABLE 256 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 227
TABLE 257 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 228
TABLE 258 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 228
TABLE 259 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 229
TABLE 260 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 229
9.6 OTHER END USERS 229
TABLE 261 NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 229
TABLE 262 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 230
TABLE 263 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 230
TABLE 264 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 231
TABLE 265 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 231
TABLE 266 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 231
10 NEXT-GENERATION SEQUENCING MARKET, BY REGION 232
10.1 INTRODUCTION 233
TABLE 267 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 233
10.2 NORTH AMERICA 234
FIGURE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT 234
TABLE 268 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 235
TABLE 269 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 235
TABLE 270 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 271 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 272 NORTH AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 273 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 237
TABLE 274 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 238
TABLE 275 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 276 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 277 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 239
10.2.1 US 240
10.2.1.1 Growing R&D activities in US to drive market growth 240
TABLE 278 US: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 241
TABLE 279 US: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 280 US: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 281 US: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 282 US: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 243
TABLE 283 US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 243
TABLE 284 US: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 285 US: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 286 US: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 245
10.2.2 CANADA 245
10.2.2.1 Increasing government initiatives in genomics research to boost adoption of NGS 245
TABLE 287 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 246
TABLE 288 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 289 CANADA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 290 CANADA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 291 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 248
TABLE 292 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 249
TABLE 293 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 294 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 295 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 250
10.2.3 NORTH AMERICA: RECESSION IMPACT 251
10.3 EUROPE 251
TABLE 296 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 251
TABLE 297 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 252
TABLE 298 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 299 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 300 EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 301 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 254
TABLE 302 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 254
TABLE 303 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 304 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 305 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 256

10.3.1 GERMANY 256
10.3.1.1 Germany dominates European next-generation sequencing market 256
TABLE 306 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 257
TABLE 307 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 308 GERMANY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 309 GERMANY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 310 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 258
TABLE 311 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 259
TABLE 312 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 313 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 314 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 260
10.3.2 UK 261
10.3.2.1 Strategic initiatives and funding for genomics research to support adoption of NGS 261
TABLE 315 UK: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 262
TABLE 316 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 317 UK: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 318 UK: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 319 UK: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 263
TABLE 320 UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 264
TABLE 321 UK: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 322 UK: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 323 UK: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 265
10.3.3 FRANCE 265
10.3.3.1 Government initiatives for genomics research to drive growth 265
TABLE 324 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 266
TABLE 325 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 326 FRANCE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 267
TABLE 327 FRANCE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 267
TABLE 328 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 267
TABLE 329 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 268
TABLE 330 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 331 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 332 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 269
10.3.4 ITALY 269
10.3.4.1 Favorable funding scenario to drive adoption of next-generation sequencing 269
TABLE 333 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 270
TABLE 334 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 335 ITALY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 336 ITALY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 337 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 271
TABLE 338 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 272
TABLE 339 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 272
TABLE 340 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 273
TABLE 341 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 273
10.3.5 SPAIN 274
10.3.5.1 Focus on expanding genomic research to support growth 274
TABLE 342 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 274
TABLE 343 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 344 SPAIN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 345 SPAIN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 346 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 276
TABLE 347 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 277
TABLE 348 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 277
TABLE 349 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 277
TABLE 350 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 278
10.3.6 NETHERLANDS 278
10.3.6.1 Focus on implementation of NGS to boost growth 278
TABLE 351 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 279
TABLE 352 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 279
TABLE 353 NETHERLANDS: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 280
TABLE 354 NETHERLANDS: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 280
TABLE 355 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 280
TABLE 356 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 281
TABLE 357 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 358 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 359 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 282
10.3.7 REST OF EUROPE 282
TABLE 360 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 283
TABLE 361 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 283
TABLE 362 REST OF EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 284
TABLE 363 REST OF EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 284
TABLE 364 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 284
TABLE 365 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 285
TABLE 366 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 285
TABLE 367 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 285
TABLE 368 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 286
10.3.8 EUROPE: RECESSION IMPACT 286
10.4 ASIA PACIFIC 287
FIGURE 31 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT 287
TABLE 369 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 288
TABLE 370 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 288
TABLE 371 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 289
TABLE 372 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 289
TABLE 373 ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 290
TABLE 374 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 290
TABLE 375 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 291
TABLE 376 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 291
TABLE 377 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 291
TABLE 378 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 292
10.4.1 CHINA 292
10.4.1.1 China to register highest growth in Asia Pacific market 292
TABLE 379 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 293
TABLE 380 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 293
TABLE 381 CHINA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 294
TABLE 382 CHINA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 294
TABLE 383 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 294
TABLE 384 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 295
TABLE 385 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 295
TABLE 386 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 296
TABLE 387 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 296
10.4.2 JAPAN 296
10.4.2.1 Rising number of collaborations for NGS to boost market growth 296
TABLE 388 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 297
TABLE 389 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 297
TABLE 390 JAPAN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 298
TABLE 391 JAPAN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 298
TABLE 392 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 298
TABLE 393 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 299
TABLE 394 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 299
TABLE 395 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 300
TABLE 396 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 300
10.4.3 INDIA 300
10.4.3.1 Government initiatives for genomics to support market growth 300
TABLE 397 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 301
TABLE 398 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 302
TABLE 399 INDIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 302
TABLE 400 INDIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 303
TABLE 401 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 303
TABLE 402 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 304
TABLE 403 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 304
TABLE 404 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 304
TABLE 405 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 305
10.4.4 AUSTRALIA 305
10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth 305
TABLE 406 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 306
TABLE 407 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 306
TABLE 408 AUSTRALIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 307
TABLE 409 AUSTRALIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 307
TABLE 410 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 307
TABLE 411 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 308
TABLE 412 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 308
TABLE 413 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 308
TABLE 414 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 309
10.4.5 REST OF ASIA PACIFIC 309
TABLE 415 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 310
TABLE 416 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 310
TABLE 417 REST OF ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 311
TABLE 418 REST OF ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 311
TABLE 419 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 311
TABLE 420 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 312
TABLE 421 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 312
TABLE 422 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 312
TABLE 423 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 313
10.4.6 ASIA PACIFIC: RECESSION IMPACT 313
10.5 LATIN AMERICA 314
TABLE 424 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 314
TABLE 425 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 314
TABLE 426 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 315
TABLE 427 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 315
TABLE 428 LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 316
TABLE 429 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 316
TABLE 430 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 317
TABLE 431 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 317
TABLE 432 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 317
TABLE 433 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 318
10.5.1 BRAZIL 318
10.5.1.1 Rising focus on clinical genomics to drive demand for NGS 318
TABLE 434 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 319
TABLE 435 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 319
TABLE 436 BRAZIL: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 320
TABLE 437 BRAZIL: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 320
TABLE 438 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 320
TABLE 439 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 321
TABLE 440 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 321
TABLE 441 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 321
TABLE 442 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 322
10.5.2 MEXICO 322
10.5.2.1 Biotechnology infrastructure development to support market growth 322
TABLE 443 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 323
TABLE 444 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 323
TABLE 445 MEXICO: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 324
TABLE 446 MEXICO: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 324
TABLE 447 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 324
TABLE 448 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 325
TABLE 449 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 325
TABLE 450 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 325
TABLE 451 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 326
10.5.3 REST OF LATIN AMERICA 326
TABLE 452 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 326
TABLE 453 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 327
TABLE 454 REST OF LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 327
TABLE 455 REST OF LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 328
TABLE 456 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 328
TABLE 457 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 329
TABLE 458 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 329
TABLE 459 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 329
TABLE 460 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 330
10.5.4 LATIN AMERICA: RECESSION IMPACT 330

10.6 MIDDLE EAST & AFRICA 331
TABLE 461 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 331
TABLE 462 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 331
TABLE 463 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 332
TABLE 464 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 332
TABLE 465 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 333
TABLE 466 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 333
TABLE 467 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 334
TABLE 468 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 334
TABLE 469 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 334
TABLE 470 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 335
10.6.1 MIDDLE EAST 335
10.6.1.1 Expansion by prominent players and launch of genomic initiatives to support growth 335
TABLE 471 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 336
TABLE 472 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 336
TABLE 473 MIDDLE EAST: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 337
TABLE 474 MIDDLE EAST: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 337
TABLE 475 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 337
TABLE 476 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 338
TABLE 477 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 338
TABLE 478 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 338
TABLE 479 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 339
10.6.2 AFRICA 339
10.6.2.1 Collaborations among market players and government bodies to boost growth 339
TABLE 480 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 340
TABLE 481 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 340
TABLE 482 AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 341
TABLE 483 AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 341
TABLE 484 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 341
TABLE 485 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 342
TABLE 486 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 342
TABLE 487 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 342
TABLE 488 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 343
10.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT 343
11 COMPETITIVE LANDSCAPE 344
11.1 INTRODUCTION 344
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 345
FIGURE 32 NEXT-GENERATION SEQUENCING MARKET: STRATEGIES ADOPTED 345
11.3 REVENUE ANALYSIS 346
FIGURE 33 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021) 346
11.4 MARKET SHARE ANALYSIS 347
FIGURE 34 NEXT-GENERATION SEQUENCING MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 347
TABLE 489 NEXT-GENERATION SEQUENCING MARKET: DEGREE OF COMPETITION 347
11.5 COMPANY EVALUATION MATRIX 349
11.5.1 STARS 349
11.5.2 EMERGING LEADERS 349
11.5.3 PERVASIVE PLAYERS 349
11.5.4 PARTICIPANTS 349
FIGURE 35 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021 350
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 351
11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 351
TABLE 490 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 351
11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 352
TABLE 491 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 352
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 353
TABLE 492 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 353
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 354
11.7.1 PROGRESSIVE COMPANIES 354
11.7.2 STARTING BLOCKS 354
11.7.3 RESPONSIVE COMPANIES 354
11.7.4 DYNAMIC COMPANIES 354
FIGURE 36 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021 355
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 356
TABLE 493 NEXT-GENERATION SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES 356
TABLE 494 NEXT-GENERATION SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 357
11.9 COMPETITIVE SCENARIO AND TRENDS 358
11.9.1 PRODUCT LAUNCHES 358
TABLE 495 NEXT-GENERATION SEQUENCING MARKET: KEY PRODUCT LAUNCHES, JANUARY 2019–DECEMBER 2022 358
11.9.2 DEALS 358
TABLE 496 NEXT-GENERATION SEQUENCING MARKET: KEY DEALS, JANUARY 2019–DECEMBER 2022 358
11.9.3 OTHER DEVELOPMENTS 359
TABLE 497 NEXT-GENERATION SEQUENCING MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2019–DECEMBER 2022 359

12 COMPANY PROFILES 360
12.1 KEY PLAYERS 360
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 ILLUMINA, INC. 360
TABLE 498 ILLUMINA, INC.: BUSINESS OVERVIEW 360
FIGURE 37 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 361
12.1.2 THERMO FISHER SCIENTIFIC, INC. 370
TABLE 499 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 370
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 371
12.1.3 PERKINELMER 381
TABLE 500 PERKINELMER: BUSINESS OVERVIEW 381
FIGURE 39 PERKINELMER: COMPANY SNAPSHOT (2021) 382
12.1.4 AGILENT TECHNOLOGIES, INC. 386
TABLE 501 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 386
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 387
12.1.5 PACIFIC BIOSCIENCES 391
TABLE 502 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW 391
FIGURE 41 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2021) 392
12.1.6 OXFORD NANOPORE TECHNOLOGIES 397
TABLE 503 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW 397
FIGURE 42 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2021) 398
12.1.7 BGI GROUP 404
TABLE 504 BGI GROUP: BUSINESS OVERVIEW 404
12.1.8 QIAGEN 411
TABLE 505 QIAGEN: BUSINESS OVERVIEW 411
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021) 412
12.1.9 F. HOFFMANN-LA ROCHE AG 421
TABLE 506 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 421
FIGURE 44 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021) 422
12.1.10 EUROFINS SCIENTIFIC 426
TABLE 507 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 426
FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 426
12.1.11 BROOKS AUTOMATION, INC. 429
TABLE 508 BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW 429
FIGURE 46 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2021) 430
12.1.12 PSOMAGEN 432
TABLE 509 PSOMAGEN: BUSINESS OVERVIEW 432
12.1.13 10X GENOMICS 434
TABLE 510 10X GENOMICS: BUSINESS OVERVIEW 434
12.1.14 TECAN TRADING GROUP 437
TABLE 511 TECAN TRADING GROUP: BUSINESS OVERVIEW 437
FIGURE 47 TECAN GROUP: COMPANY SNAPSHOT (2021) 438
12.1.15 ZYMO RESEARCH 440
TABLE 512 ZYMO RESEARCH: BUSINESS OVERVIEW 440
12.1.16 TAKARA BIO 442
TABLE 513 TAKARA BIO: BUSINESS OVERVIEW 442
FIGURE 48 TAKARA BIO: COMPANY SNAPSHOT (2021) 443
12.1.17 PROMEGA CORPORATION 446
TABLE 514 PROMEGA CORPORATION: BUSINESS OVERVIEW 446
12.1.18 CD GENOMICS 449
TABLE 515 CD GENOMICS: BUSINESS OVERVIEW 449
12.1.19 NEW ENGLAND BIOLABS 454
TABLE 516 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 454
12.1.20 NOVOGENE CORPORATION INC. 460
TABLE 517 NOVOGENE CORPORATION INC.: BUSINESS OVERVIEW 460
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 463
12.2.1 HAMILTON COMPANY 463
12.2.2 MEDGENOME 464
12.2.3 BECTON, DICKINSON AND COMPANY 465
12.2.4 COSMOSID, INC. 466
12.2.5 GENOTYPIC TECHNOLOGY 467
12.2.6 LGC LIMITED 468

13 APPENDIX 469
13.1 DISCUSSION GUIDE 469
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 474
13.3 CUSTOMIZATION OPTIONS 476
13.4 RELATED REPORTS 476
13.5 AUTHOR DETAILS 477

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 시장 (~2027년) : 제품 및 서비스별 (소모품, 플랫폼, 서비스), 기술별 (SBS, 나노포어), 용별도 (진단, 신약 개발, 농업), 최종 용도별 (제약, 생명 공학, 교육)] (코드 : BT2697-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 시장 (~2027년) : 제품 및 서비스별 (소모품, 플랫폼, 서비스), 기술별 (SBS, 나노포어), 용별도 (진단, 신약 개발, 농업), 최종 용도별 (제약, 생명 공학, 교육)] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 차세대 염기서열 분석 시장 (~2029년) : 제품 유형별 (소모품, 플랫폼, 생물정보학), 기술별 (SBS, 나노포어), 워크플로별 (염기서열 분석, 데이터 분석), 서비스별, 응용 분야별 (신약 개발, 진단, 농업)
BT 2697 / MarketsandMarkets / 2025년 1월 / ...2023년 121억 3천만 달러 규모로 추정되는 글로벌 차세대 염기서열 분석 시장은 2024년 126억 5천만 달러, 2029년 235억 5천만 달러에 이를 것으로 전망되며, 연평균 13.2%의 높은 성장률을 보일 것으로 예상됩니다. NGS 시장의 주요 성장 동력은 유전자 돌연변이 및 바이오마커를 식별하는 정밀 의학에 대한 수요 증가로, 이로 인해 전 세계적으로 표적 치료법과...

세계의 엑소좀 연구 시장 (~2028년) : 제품 및 서비스별 (키트, 시약 (항체, 분리 정제), 기기), 질환별 (암, 감염), 용도별 (바이오 마커, 백신), 제조 서비스별 (줄기 세포)
BT6939-24 / MarketsandMarkets / 2024년 1월 / "글로벌 엑소좀 연구 시장은 2023년 약 1억 6900만 달러에서 2028년 35억 6000만 달러에 달할 것으로 예상되며, 예측 기간 동안 16.0%의 CAGR을 기록할 것으로 전망됩니다." 이 시장의 성장은 암, 신경 퇴행성...1. 서론 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 엑소좀 연구 시장 규모 : 제품 및 서비스별 7. 세계의 엑소좀 연구 시장 규모 : 질환별 8. 세계의 엑소좀 연구 시장 규모 : 용도별 9. 세계의 엑소좀 연구 시장 규모 : 최종 용도별 10. 세계의...

세계의 감염 감시 솔루션 시장 (~2027년) : 소프트웨어별 (온프레미스, 웹 기반), 서비스별 (제품 지원 및 유지 보수, 실장, 교육 및 컨설팅), 최종 용도별 (병원, 장기 요양 시설), 지역별
HIT4380-23 / MarketsandMarkets / 2023년 2월 / MarketsandMarkets사의 본 보고서는 세계의 감염 감시 솔루션 시장 규모가 2022년 577백만 달러에 이르며, 2027년까지 1,100백만 달러로 확대될 것으로 예상하고 있습니다. 덧붙여 예측 기간 동안 연평균 13.8%로 성장할 것으로 전망하고 있습니다....“The infection surveillance solutions market is anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period.” The market has a promising growth potential due to increased demand the increasing prevalence of hospital-acquired infections, increasing...

세계의 스마트 철도 시장 (~2027년) : 솔루션별 (철도 자산 관리 및 유지 보수, 운영 및 제어, 통신 및 네트워크, 보안 및 안전, 철도 분석), 서비스별 (전문 서비스 및 매니지드 서비스), 지역별
TC1417-23 / MarketsandMarkets / 2023년 1월 / MarketsandMarkets사에 따르면 세계의 스마트 철도 시장 규모는 2022년 289억 달러에서 2027년 430억 달러까지 연평균 8.3% 성장할 것으로 추정하고 있습니다. 본 조사 보고서는 세계의 스마트 철도 시장에 대해 조사 및 분석하여,...“MarketsandMarkets projects the smart railways market to grow from USD 28.9 billion in 2022 to USD 43.0 billion by 2027 at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.” The requirement for urban connectivity is predicted to expand along with the integration of IoT-based solutions and...

세계의 수술용 로봇 시장 (~2027년) : 제품 및 서비스별 (기기, 로봇 시스템, 서비스), 용도별 (일반 외과, 부인과, 정형 외과, 신경 외과), 최종 용도별 (병원, 외래 수술 센터)
MD6781-23 / MarketsandMarkets / 2023년 1월 / MarketsandMarkets사는 세계의 수술용 로봇 시장 규모가 2022년 85억 달러에서 2027년 184억 달러에 이르며, 예측 기간 동안 연평균 16.6%로 성장할 것으로 추정하고 있습니다. 본 조사 보고서는 세계의 수술용 로봇 시장을 조사...“The global surgical robots market is projected to reach USD 18.4 billion by 2027 from an estimated USD 8.5 billion in 2022, at a CAGR of 16.6% during the forecast period.” The advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, improving reimbursement scenario,...